These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2889433)

  • 1. Interaction of pathogenic and nonpathogenic Entamoeba histolytica with human complement.
    Reed SL; Gault M; Gillin FD; Gigli I; Braude AI; Curd JG; Sargeaunt PG
    Arch Invest Med (Mex); 1987; 18(2):141-9. PubMed ID: 2889433
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
    Reed SL; Curd JG; Gigli I; Gillin FD; Braude AI
    J Immunol; 1986 Mar; 136(6):2265-70. PubMed ID: 2869084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of the alternative complement pathway by various axenic strains of Entamoeba histolytica].
    Capin NR; Capin R; Zamacona G; Ortiz-Ortiz L
    Arch Invest Med (Mex); 1978; 9 Suppl 1():291-6. PubMed ID: 211963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement resistance of pathogenic Entamoeba histolytica mediated by trypsin-sensitive surface component(s).
    Hamelmann C; Urban B; Foerster B; Horstmann RD
    Infect Immun; 1993 May; 61(5):1636-40. PubMed ID: 8478051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA; Mull JC; Major PC
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence of Entamoeba histolytica correlates with the capacity to develop complement resistance.
    Mogyoros M; Calef E; Gitler C
    Isr J Med Sci; 1986 Dec; 22(12):915-7. PubMed ID: 2883155
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysozyme and complement-dependent lysis of Entamoeba histolytica. Inhibition by leupeptin.
    Mogyoros M; Fishelson Z; Gitler C
    Isr J Med Sci; 1986 Dec; 22(12):918-20. PubMed ID: 2883156
    [No Abstract]   [Full Text] [Related]  

  • 8. Entamoeba histolytica: an explanation for the reported conversion of "nonpathogenic" amebae to the "pathogenic" form.
    Clark CG; Diamond LS
    Exp Parasitol; 1993 Dec; 77(4):456-60. PubMed ID: 8253159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpathogenic Entamoeba dispar quickly outgrows pathogenic Entamoeba histolytica in mixed xenic cultures.
    Pysova I; Tumova P; Tolarova V; Nohynkova E
    Lett Appl Microbiol; 2009 Apr; 48(4):500-3. PubMed ID: 19187490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysis.
    Hamelmann C; Foerster B; Burchard GD; Horstmann RD
    Parasite Immunol; 1992 Jan; 14(1):23-35. PubMed ID: 1557228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
    Calderon J; Schreiber RD
    Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic versus nonpathogenic Entamoeba histolytica.
    Mirelman D
    Infect Agents Dis; 1992 Feb; 1(1):15-8. PubMed ID: 1365522
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracts of wheat gluten activate complement via the alternative pathway.
    Unsworth DJ; Würzner R; Brown DL; Lachmann PJ
    Clin Exp Immunol; 1993 Dec; 94(3):539-43. PubMed ID: 8252813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of pathogenicity of Entamoeba histolytica by polymerase chain reaction].
    Cheng XJ; Tachibana H; Kobayashi S; Kaneda Y; Huang MY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(3):172-5. PubMed ID: 8168237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
    Ohta H; Yoshikawa Y; Kai C; Yamanouchi K; Okada H
    Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic activity in periodontal disease. II. The generation of complement-derived chemotactic factors.
    Okada H; Silverman MS
    J Periodontal Res; 1979 Mar; 14(2):147-52. PubMed ID: 155734
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
    Ferrante A; Rowan-Kelly B
    Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
    Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
    J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.